Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Modelling Single Cell B-Cell Receptor Signaling Reveals Enhanced Activity in Primary CLL Cells Compared to Non-Malignant Cells While Fundamental Network Circuit Topology Remains Stable Even with Novel Therapeutic Inhibitors

Daniel Mertens, PhD, Christine Wolf, PhD, Carsten Maus, PhD, Michael Persicke, Katharina Filarsky, PhD, Hartmut Döhner, Peter Lichter, PhD, Thomas Höfer, PhD, Stephan Stilgenbauer, MD

Blood (2019) 134 (Supplement_1): 4275.

https://doi.org/10.1182/blood-2019-127837

Published: 2019

Journal Articles

Exhausted PD-1 hi T-Cells Are Enriched in Secondary Lymphoid Organs of CLL Patients

Philipp M Rößner, Bola S Hanna, PhD, Colomer Dolors, PhD, Elias Campo, MD PhD, Stephan Stilgenbauer, MD PhD, Peter Lichter, PhD, Martina Seiffert

Blood (2017) 130 (Supplement 1): 4281.

https://doi.org/10.1182/blood.V130.Suppl_1.4281.4281

Published: 2017

Journal Articles

PI3K-δ Inhibition Influences T-Cell Populations and Anti-Tumoral Immune Function in Preclinical Models

Annika Scheffold, Bola S Hanna, PhD, Philipp Roeßner, Yasmin Demerdash, Billy Michael Chelliah Jebaraj, PhD, Peter Lichter, PhD, Stephan Stilgenbauer, MD PhD, Martina Seiffert

Blood (2017) 130 (Supplement 1): 2998.

https://doi.org/10.1182/blood.V130.Suppl_1.2998.2998

Published: 2017

Journal Articles

IL-10 Receptor Deficiency Aggravates Exhaustion of CD8 + T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia

Bola S Hanna, PhD, Philipp M Röβner, Murat Iskar, PhD, Norman Mack, Verena Kalter, Manfred Schmidt, PhD, Marc Zapatka, PhD, Markus Feuerer, MD, Richard Gabriel, PhD, Peter Lichter, PhD, Martina Seiffert

Blood (2017) 130 (Supplement 1): 385.

https://doi.org/10.1182/blood.V130.Suppl_1.385.385

Published: 2017

Journal Articles

CLL Exosome-Derived Y RNA hY4 Induces TLR7/8-Mediated Inflammation and PD-L1 Expression in Monocytes

Franziska Haderk, MSc, Laura Llao Cid, MSc, Murat Iskar, PhD, Ralph Schulz, MSc, Maria Goebel, MD, Jan Duerig, MD, Stephan Stilgenbauer, Marc Zapatka, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2016) 128 (22): 3217.

https://doi.org/10.1182/blood.V128.22.3217.3217

Published: 2016

Journal Articles

The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling

Claudia Dürr, Bola Hanna, Fabienne McClanahan, MD, Andrew James Clear, BSc, Thorsten Zenz, MD, Stephan Stilgenbauer, MD, John G. Gribben, MD DSc, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2014) 124 (21): 1966.

https://doi.org/10.1182/blood.V124.21.1966.1966

Published: 2014

Journal Articles

Chronic Lymphocytic Leukemia-Derived Extracellular Vesicles Contain a Distinctive Proteome, As Well As Specific Micro RNAs and Y RNAs

Franziska Haderk, Etienne Moussay, Jerome Paggetti, Maria Göbel, Jan Dürig, MD, Thorsten Zenz, MD, Stephan Stilgenbauer, MD, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2014) 124 (21): 1968.

https://doi.org/10.1182/blood.V124.21.1968.1968

Published: 2014

Journal Articles

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model

Bola Hanna, Fabienne McClanahan, MD, Nadja Zaborsky, PhD, Claudia Dürr, Verena Kalter, Alexander Egle, MD, John G. Gribben, MD DSc, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2014) 124 (21): 3298.

https://doi.org/10.1182/blood.V124.21.3298.3298

Published: 2014

Journal Articles

Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

Bola Hanna, Fabienne McClanahan, MD, Andrew James Clear, BSc, Shaun Miller, Peter Lichter, PhD, Martina Seiffert, PhD, John G. Gribben, MD DSc

Blood (2014) 124 (21): 717.

https://doi.org/10.1182/blood.V124.21.717.717

Published: 2014

Journal Articles

NFATc1 Is Transcriptionally Activated in Chronic Lymphocytic Leukemia (CLL) By Promotor DNA-Hypomethylation Which Correlates with in-Vitro Vulnerability to Calcineurin Inhibitors

Christine Wolf, Katharina Filarsky, Angela Garding, PhD, Rainer Claus, MD, Christopher C Oakes, PhD, Irina Idler, PhD, Christoph Plass, PhD, Peter Lichter, PhD, Hartmut Doehner, MD, Stephan Stilgenbauer, MD, Daniel Mertens, PhD

Blood (2014) 124 (21): 1941.

https://doi.org/10.1182/blood.V124.21.1941.1941

Published: 2014

Journal Articles

Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia

Christopher C Oakes, Ph.D, Rainer Claus, MD, Lei Gu, Yassen Assenov, Jennifer Hüllein, Manuela Zucknick, David Brocks, Olga Bogatyrova, Christopher R. Schmidt, Laura Rassenti, PhD, Thomas J. Kipps, MD, PhD, Daniel Mertens, PhD, Peter Lichter, PhD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, John C. Byrd, MD, Thorsten Zenz, MD, Christoph Plass, PhD

Blood (2013) 122 (21): 1626.

https://doi.org/10.1182/blood.V122.21.1626.1626

Published: 2013

Journal Articles

Microenvironmental Factors and The Role Of Tumor Necrosis Factor Receptor Type 1 (TNFR-1) In Chronic Lymphocytic Leukemia

Claudia Duerr, Angela Schulz, PhD, Sibylle Ohl, Thorsten Zenz, MD, Stephan Stilgenbauer, MD, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2013) 122 (21): 4149.

https://doi.org/10.1182/blood.V122.21.4149.4149

Published: 2013

Journal Articles

Lenalidomide Reduces Survival of Chronic Lymphocytic Leukemia Cells in Primary Co-Cultures by Altering the Myeloid Microenvironment

Angela Schulz, PhD, Claudia Dürr, Thorsten Zenz, MD, Stephan Stilgenbauer, MD, Peter Lichter, PhD, Martina Seiffert, PhD

Blood (2012) 120 (21): 3894.

https://doi.org/10.1182/blood.V120.21.3894.3894

Published: 2012

Journal Articles

NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances

Frank G. Rücker, MD, Lars Bullinger, MD, Frank Stegelmann, MD, Carmen Blersch, Peter Lichter, PhD, Jürgen Krauter, MD, Brigitte Schlegelberger, MD, PhD, Arnold Ganser, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD

Blood (2010) 116 (21): 4179.

https://doi.org/10.1182/blood.V116.21.4179.4179

Published: 2010

Journal Articles

Genetics of Patients with F-Refractory CLL or Early Relapse After FC or FCR: Results From the CLL8 Trial of the GCLLSG

Thorsten Zenz, MD, Raymonde Busch, Anna Fink, MD, Dirk Winkler, MD, Kirsten Fischer, MD, Andreas Bühler, MD, Patrick Hoth, Gunter R. Fingerle-Rowson, MD, PhD, Michael Kneba, MD, PhD, Sebastian Boettcher, MD, Ulrich Jäger, MD, Myriam Mendila, MD, Michael Wenger, MD, Peter Lichter, PhD, Michael Hallek, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD

Blood (2010) 116 (21): 2427.

https://doi.org/10.1182/blood.V116.21.2427.2427

Published: 2010

Journal Articles

Identification of High-Level DNA Amplifications in AML with Complex Karyotype Using Array-CGH.

Frank G. Rücker, MD, Lars Bullinger, MD, Simone Miller, Hans A. Kestler, PhD, Peter Lichter, PhD, Konstanze Dohner, MD, Hartmut Dohner, MD

Blood (2006) 108 (11): 1914.

https://doi.org/10.1182/blood.V108.11.1914.1914

Published: 2006

Journal Articles

Array-CGH Based Genomic Profiling in B-Cell Chronic Lymphocytic Leukemia Reveals Specific Correlations of Genomic Imbalances and Prognostic Subgroups and Underlines the Consistency of Chromosomal Aberration Patterns within This Disease.

Carsten Schwaenen, MD, Dirk Kienle, MD, Alexander Krober, MD, Sandra Ruf, Dirk Winkler, MD, Holger Kohlhammer, MD, Hans A. Kestler, PhD, Peter Lichter, PhD, Swen Wessendorf, MD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD

Blood (2006) 108 (11): 2083.

https://doi.org/10.1182/blood.V108.11.2083.2083

Published: 2006

Journal Articles

Disclosure of Copy Number Alterations in AML with Normal Karyotype Using Matrix-Based Comparative Genomic Hybridization.

Frank G. Rucker, MD, Lars Bullinger, MD, Hans A. Kestler, Peter Lichter, PhD, Konstanze Dohner, MD, Hartmut Dohner, MD

Blood (2005) 106 (11): 759.

https://doi.org/10.1182/blood.V106.11.759.759

Published: 2005

Journal Articles

Parallel Analyses Disclose Novel Genomic Imbalances in Acute Myeloid Leukemia with Complex Karyotypes.

Frank G. Rucker, MD, Lars Bullinger, MD, Hans A. Kestler, Peter Lichter, PhD, Konstanze Dohner, MD, Hartmut Dohner, MD

Blood (2005) 106 (11): 2357.

https://doi.org/10.1182/blood.V106.11.2357.2357

Published: 2005

Journal Articles

Characterization of Secondary Alterations in Mantle Cell Lymphomas Using Matrix-/Array CGH.

Doris Steinemann, PhD, Marcel Tauscher, Cornelia Rudolph, Makito Emura, PhD, M. Abe, MD, M. Daibata, MD, Yoshinobu Matsuo, MD, PhD, Hans G. Drexler, PhD, Bernhard Radlwimmer, PhD, Hans A. Kestler, PhD, Peter Lichter, PhD, Brigitte Schlegelberger, MD, PhD

Blood (2004) 104 (11): 4349.

https://doi.org/10.1182/blood.V104.11.4349.4349

Published: 2004

NARROW

Modelling Single Cell B-Cell Receptor Signaling Reveals Enhanced Activity in Primary CLL Cells Compared to Non-Malignant Cells While Fundamental Network Circuit Topology Remains Stable Even with Novel Therapeutic Inhibitors

Exhausted PD-1 hi T-Cells Are Enriched in Secondary Lymphoid Organs of CLL Patients

PI3K-δ Inhibition Influences T-Cell Populations and Anti-Tumoral Immune Function in Preclinical Models

IL-10 Receptor Deficiency Aggravates Exhaustion of CD8 + T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia

CLL Exosome-Derived Y RNA hY4 Induces TLR7/8-Mediated Inflammation and PD-L1 Expression in Monocytes

The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling

Chronic Lymphocytic Leukemia-Derived Extracellular Vesicles Contain a Distinctive Proteome, As Well As Specific Micro RNAs and Y RNAs

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model

Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

NFATc1 Is Transcriptionally Activated in Chronic Lymphocytic Leukemia (CLL) By Promotor DNA-Hypomethylation Which Correlates with in-Vitro Vulnerability to Calcineurin Inhibitors

Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia

Microenvironmental Factors and The Role Of Tumor Necrosis Factor Receptor Type 1 (TNFR-1) In Chronic Lymphocytic Leukemia

Lenalidomide Reduces Survival of Chronic Lymphocytic Leukemia Cells in Primary Co-Cultures by Altering the Myeloid Microenvironment

NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances

Genetics of Patients with F-Refractory CLL or Early Relapse After FC or FCR: Results From the CLL8 Trial of the GCLLSG

Identification of High-Level DNA Amplifications in AML with Complex Karyotype Using Array-CGH.

Array-CGH Based Genomic Profiling in B-Cell Chronic Lymphocytic Leukemia Reveals Specific Correlations of Genomic Imbalances and Prognostic Subgroups and Underlines the Consistency of Chromosomal Aberration Patterns within This Disease.

Disclosure of Copy Number Alterations in AML with Normal Karyotype Using Matrix-Based Comparative Genomic Hybridization.

Parallel Analyses Disclose Novel Genomic Imbalances in Acute Myeloid Leukemia with Complex Karyotypes.

Characterization of Secondary Alterations in Mantle Cell Lymphomas Using Matrix-/Array CGH.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only